Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Volt Pharma Associates

VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

Volt Pharma Associates
Engesserstrasse 4B, Freiburg, 79114, Germany
+49 172 6340202
Contact Volt Pharma Associates
Website

 Latest Content from PMHub 

A Bitter Pill?

White Papers and Resources | December 14, 2016 | Inizio

The ideal route of admin isn’t clear cut in the global marketplace

2017: Medical education that improves value and outcomes for patients

Press Releases | December 12, 2016 | Lucid Group Communications Limited

In December’s Issue of PME, two of Lucid’s senior management team – Shula Sarner and Tanya Goodyear – consider how medical education will evolve in 2017.   They discuss industry...

How can pharma engage with NHS Vanguards?

White Papers and Resources | December 12, 2016 | Wilmington Healthcare

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore the opportunities for pharma to help NHS vanguards develop new models of care.

Webinar: Become your customer’s chosen channel

White Papers and Resources | December 8, 2016 | Anthill Agency

Your customer now expects to access knowledge in any format and at any time that they desire. But how do you become the ever-present partner that they trust and value...

Understanding the chronic disease patient journey in emerging markets

White Papers and Resources | December 7, 2016 | Inizio

In this paper, we will explore the chronic disease patient journey in emerging markets and provide you with the insights you require to identify the key inflection points in these...

Infographic: Keeping tracking on track

White Papers and Resources | December 7, 2016 | Inizio

Our best practice approach to tracking studies.

Lucid Group kick off their Winter Festival

Press Releases | December 6, 2016 | Lucid Group Communications Limited

The start of December not only signalled the official calendar countdown to Christmas, but also marked the official launch of the Lucid Winter Festival, which culminates in the Winter Summit...

What does the Five Year Forward View mean for pharma?

White Papers and Resources | December 6, 2016 | Wilmington Healthcare

Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess how the Five Year Forward View (5YFV) is changing the NHS and how pharma can get involved in redesigning NHS services.

Healthcare in the Digital Age

White Papers and Resources | December 3, 2016 | M3 (EU)

Healthcare is changing. By understanding the needs of the physicians, and using innovative channels to make meaningful connections, pharma can ensure it continues to enjoy a mutually beneficial relationship.

M3 announces further expansion into Europe and Latin America with the acquisition of Vidal Group

Press Releases | December 3, 2016 | M3 (EU)

M3 is strengthening and growing its global operations with the acquisition of Vidal Group, a trusted provider of prescribing information and clinical decision support services to doctors and other HCPs...